Annual Drug Patent Expirations for VERKAZIA
Verkazia is a drug marketed by Santen and is included in one NDA. It is available from one supplier. There are six patents protecting this drug.
This drug has ninety-four patent family members in twenty-three countries.
The generic ingredient in VERKAZIA is cyclosporine. One supplier is listed for this compound. Additional details are available on the cyclosporine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com